Publications
57 publications
Funding
10 grants
Active
1 grant- Sub-PIU24AG057437-06Longitudinal Follow up of Clinical Trial Participants For Brain DonationNational Institute on Aging · 2023–2028 · via University of Southern California
Completed grants (9)
- Sub-PIR01AG061848-03Brain DonationNational Institute on Aging · 2022–2024 · via University of Southern California
- Sub-PIR01AG063689-03A4-OLE - Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension StudyNational Institute on Aging · 2019–2023 · via University of Southern California
- Sub-PIUSC 16101659-03Tau PET Imaging for the USC Alzheimer's Therapeutic Research Institute (USC ATRI) A4 Trial (“A4 TAU”)Foundation for the National Institutes of Health, Inc. · 2015–2023 · via University of Southern California
- Sub-PIR01AG062624-02Metformin in Alzheimer’s dementia Prevention (MAP)National Institute on Aging · 2019–2021 · via Columbia University
- Co-IR56AG064873-01Understanding the dynamic interactions between tau pathology and microglia-mediated inflammation in Alzheimer's DiseaseNational Institute on Aging · 2019–2021
- Sub-PIU19AG010483-26Alzheimer’s Disease Cooperative Study – A4 StudyNational Institute on Aging · 2015–2020 · via University of Southern California
- Sub-PIWEI1808-1916 EWOFEffects of Traumatic Brain Injury and Post-Traumatic Stress Disorder on Alzheimer's Disease (AD) in Veterans With Mild Cognitive Impairment (MC) Using the Alzheimer's Disease Neuroimaging InitiativeU.S. Department of Defense · 2015–2019 · via University of Southern California
- Sub-PIWEI1808-1915ADNI-DOD: Effects of Traumatic Brain Injury and Posttraumatic Stress Disorder On Alzheimer's Disease in Veterans Using ADNIU.S. Department of Defense · 2015–2019 · via University of Southern California
- Sub-PIWEI1872-06Effects of Traumatic Brain Injury and Post-Traumatic Stress Disorder and Alzheimer's Disease on Brain Tau in Vietnam Veterans Using ADNIU.S. Department of Defense · 2015–2018 · via University of Southern California
Clinical research
1 study
Completed & closed trials (1)
- PINCT04241068Phase 3b Open-Label, Multicenter, Safety Study of BIIB037 (Aducanumab) in Subjects With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205PHASE3 · Biogen, Inc. · IRB STUDY CLOSURE (as of 2025)Alzheimer's Disease